Background: Malaria is extremely common in Ethiopia, and it is one of the country's most serious public health and economic problems. Traditional medicines have long been utilized in Ethiopia by people of various ethnic groups. As a result, the goal of this study is to record the use of Ethiopian medicinal herbs that have been used to treat malaria. Also, a critical review of the literature on the therapeutic properties of these and other Ethiopian medicinal plants that have been tested againstPlasmodiumspp.parasites was conducted with the goal of highlighting neglected studies and fostering further research in this area.Methods: A comprehensive literature search was performed in Scopus, Web of Science Core Collection, PubMed, Science Direct, Google Scholar, and Scientific Electronic Library Online (SciELO) from August 2021 to October 2021. The study databases included original articles published in peer reviewed journals covering anti-malarial plants, dated until October 2021.Results: The review looked at 51 plant species (28 families) that have been used to treat malaria in Ethiopia. The most often used ethnobotanical plant species for the treatment of malaria wereAllium sativum,Croton macrostachyus,Carica papaya, andLepidium sativum. Leaves were used more frequently as a therapeutic preparation than other parts. Plant extracts were found to have very good, good, and moderate anti-malarial activity in mice with rodentPlasmodiumspecies. The most active species wereAjuga remotaandCapsicum frufescens, which suppressed parasitaemia by 77.34% and 72.65%, respectively, at an oral dose of 100 mg/kg and an LD₅₀of above 2000 mg/kg. The compound Aloinoside reported fromAloe macrocarpaleave latex was the most potent; it suppressed parasitaemia by 100% at 400 mg/kg oral dose ofPlasmodium bergheiinfected mice, and its LD₅₀was above 2000 mg/kg. Toxicity was shown to be safe in 84% of the plant extracts.Conclusion: In Ethiopia, medicinal plants have a significant part in reducing the severity of malaria due to their widespread use. As a result, more studies are needed to identify and develop effective novel drugs that could be employed in broader malaria eradication efforts.

Rhamnus prinoides L’Herit belongs to Rhamnaceae family widely distributed in India, Eastern, Central and Southern Africa. In Ethiopia it is commonly known as Gesho (Amharic, Tigrigna and Afan Oromo), Gishe (Guragegna) and Geshu (Agewgna). Decoction of the leaves is recommended as remedy for treatment of variety of diseases such as back pain, malaria, pneumonia, sexually transmitted disease, skin infections, wounds, blood purifiers, water borne diseases and as ethnoveterinary medicine. Various secondary metabolites such as flavonoids, alkaloids, tannins, terpenoids, saponins, steroids and anthraquinones have been reported from the genus of which polyphenols were abundant with tremedousantioxidant, wound healing and antiinflammatory activities. The plant also serve as hopping agent, making traditional alcoholic beverages like tella and tej (in Ethiopia), animal feed, medicine, nectar for bees, soil conservation, ornamental, shade and dyes in textiles. This review presents chemical profile as well as biological activities of the species which confirmed that the plant is a good source natural polyphenols and provided valuable information in support of its use as an alternative medicine for future healthcare practice.

Background. Shigellosis is the most common cause of epidemic dysentery found worldwide, particularly in developing countries, where it causes infant diarrhea and mortality. The prevalence of Shigella species resistant to commonly used antimicrobial drugs has steadily increased. The purpose of this review is to describe the prevalence and antimicrobial resistance (AMR) characteristics of Shigella species in East Africa between 2015 and 2022. Methods. Studies were identified using a computerized search of Medline/PubMed, Google Scholar, and Web of Science databases, with a detailed search strategy and cross-checking of reference lists for studies published between 2015 and 2022. Articles presenting data on prevalence and AMR, accessibility of the full-length article, and publication dates between 2015 and 2022 were the eligibility criteria for inclusion in the review. Original research reports written in English were considered. The heterogeneities of the studies were examined, and a meta-analysis was performed to estimate the pooled prevalence and AMR using a random effects model. Results. The pooled prevalence of Shigella species in East Africa was 6.2% (95% CI −0.20–12.60), according to an analysis of 22 studies. Shigella species prevalence was 4.0% in Ethiopia, 14.6% in Kenya, 0.7% in Sudan, 5.2% in South Sudan, and 20.6% in Somalia. The association of Shigella infection significantly varied among the countries ( ). Among the antibiotics tested, most Shigella isolates were susceptible to ciprofloxacin, norfloxacin, nalidixic acid, and ceftriaxone. Despite the fact that the reports varied in study sites and time, Shigella species were resistant to tetracycline, ampicillin, amoxicillin, chloramphenicol, and co-trimoxazole. Conclusion. The pooled estimate indicates high burden of Shigella infection in East Africa, as well as a high proportion of drug resistance pattern to tetracycline, ampicillin, chloramphenicol, and amoxicillin. Therefore, initiating and scale-up of performing drug susceptibility test for each shigellosis case need to be considered and strengthened.

The genus Rhamnus belongs to the Rhamnaceae family, which contains approximately 137 species, traditionally used as folk medicine in East Asia, North and South America, and subtropical regions of Africa. The genus is used traditionally to treat diseases such as cancer, wound, jaundice, hepatitis, gonorrhea, laxative, hypertension, malaria, stomach ache, snake bite and diarrhea. Anthraquinones and flavonoids are the most cited compounds from the genus of which polyphenols were abundant with tremendous antioxidant, wound healing and antiinflammatory activities. Pharmacological activity evaluation of the extracts and isolated compounds revealed anti-inflammatory, antioxidant, antimalarial, antibacterial, anti-mutagenic, anti-genotoxic, hepatoprotective, anticancer, and anti-proliferative activity. The genus afforded drug leads such as 6-methoxysorigenin (12) and prinoidin (23) with anti-tyrosinase and cytotoxicity, respectively, as well as antioxidant drug leads such as Kaempferol-3-O-β-rhamninoside (31) rhamnetin-3-O-β-isorhamninoside (37) and isotorachrysone (55). The present review endeavors to provide a comprehensive and up to date compilation of documented traditional medicinal uses, phytochemicals and pharmacological activities of the genus and provided valuable information in support of its uses as an alternative medicine for future healthcare practice.

Rumex abyssinicus is a valuable medicinal plant species that is native to tropical Africa. Traditionally, R. abyssinicus is used to treat different disease such as, liver diseases, hepatitis, malaria, scabies, blood pressure, jaundice, wound and pneumonia. The purpose of the current study was to review the literature on the ethnomedicinal uses, chemical constitutes and biological activities of R. abyssinicus in an attempt to create information for future studies aimed towards exploring the therapeutic ability of the species. A scientific search engines, namely Google Scholar, PubMed, Scopus, Science Direct and Web of knowledge for the search terms: Rumex abyssinicus, ethnomedicinal studies, phytochemical investigations, and pharmacological activities were undertaken. The search strategy included all articles with descriptors that were available until December 30, 2021. Only published works in English have been used on this study. The data was collected using textual descriptions of the studies, tabulation, grouping, and figures. The principal phytochemicals of R. abyssinicus are anthraquinones, flavonoids, terepenoids and phenolic compounds. The in vitro and in vivo studies on the crude extracts and compounds of R. abyssinicus showed antibacterial, antioxidant, anticancer, anti-inflammatory, antifungal, wound healing, antialzeimer’s and hepatoprotective activities of it. R. abyssinicus afforded drug leads such as helminthosporin (4) with anti-alzheimer and physicon (3) with antifungal and antioxidant activity. R. abyssinicus have traditionally been used to cure a variety of diseases. Pharmacological actions of phytochemicals were shown to be promising. Despite this, further studies on crude extracts and promising compounds are needed to find new drug candidates.

Background. Free radicals are very reactive molecules produced during oxidation events that in turn initiate a chain reaction resulting in cellular damage. Many degenerative diseases in humans, including cancer and central nervous system damage, are caused by free radicals. Scientific evidence indicates that active compounds from natural products can protect cells from free radical damage. As a result, the aim of this review is to provide evidence of the use of diverse Ethiopian medicinal plants with antioxidant properties that have been scientifically validated in order to draw attention and foster further investigations in this area. Methods. The keywords antioxidant, radical scavenging activities, reactive oxygen species, natural product, Ethiopian Medicinal plants, and 2, 2‐Diphenyl‐1‐picrylhydrazyl radical scavenging assay (DPPH) were used to identify relevant data in the major electronic scientific databases, including Google Scholar, ScienceDirect, PubMed, Medline, and Science domain. All articles with descriptions that were accessed until November 2022 were included in the search strategy. Results. A total of 54 plant species from 33 families were identified, along with 46 compounds isolated. More scientific studies have been conducted on plant species from the Brassicaceae (19%), Asphodelaceae (12%), and Asteraceae (12%) families. The most used solvent and extraction method for plant samples are methanol (68%) and maceration (88%). The most examined plant parts were the leaves (42%). Plant extracts (56%) as well as isolated compounds (61%) exhibited significant antioxidant potential. The most effective plant extracts from Ethiopian flora were Bersama abyssinica, Solanecio gigas, Echinops kebericho, Verbascum sinaiticum, Apium leptophyllum, and Crinum abyssinicum. The best oxidative phytochemicals were Rutin (7), Flavan‐3‐ol‐7‐O‐glucoside (8), Myricitrin (13), Myricetin‐3‐O‐arabinopyranoside (14), 7‐O‐Methylaloeresin A (15), 3‐Hydroxyisoagatholactone (17), β‐Sitosterol‐3‐O‐β‐D‐glucoside (22), Microdontin A/B (24), and Caffeic acid (39). Conclusion. Many crude extracts and compounds exhibited significant antioxidant activity, making them excellent candidates for the development of novel drugs. However, there is a paucity of research into the mechanisms of action as well as clinical evidence supporting some of these isolated compounds. To fully authenticate and then commercialize, further investigation and systematic analysis of these antioxidant‐rich species are required.